Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Jordan flag Jordan · Delayed Price · Currency is JOD
1.140
-0.010 (-0.87%)
At close: Jul 31, 2025
-0.87%
Market Cap39.90M
Revenue (ttm)81.54M
Net Income (ttm)4.14M
Shares Out35.00M
EPS (ttm)0.12
PE Ratio9.68
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,962
Average Volume9,209
Open1.120
Previous Close1.150
Day's Range1.120 - 1.150
52-Week Range1.100 - 1.320
Beta0.24
RSI42.98
Earnings DateJul 31, 2025

About Sage Therapeutics

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. It operates through Medicine; and Infants’ Cereals and Milk Formula segments. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatolog... [Read more]

Industry Pharmaceutical Preparations
Founded 1975
Employees 1,111
Stock Exchange Amman Stock Exchange
Ticker Symbol DADI
Full Company Profile

Financial Performance

In 2024, ASE:DADI's revenue was 81.18 million, an increase of 8.42% compared to the previous year's 74.88 million. Earnings were 3.59 million, an increase of 13.41%.

Financial Statements

News

There is no news available yet.